| Genome sequences of BCG Pasteur ATCC 35734 and its derivative, the vaccine candidate BCGΔBCG1419c. | 10.1186/s12864-023-09169-9 | 2023-02-10 |
| Recent Developments in Mycobacteria-Based Live Attenuated Vaccine Candidates for Tuberculosis | 10.3390/biomedicines10112749 | 2022-10-29 |
| Human Pulmonary Tuberculosis: Understanding the Immune Response in the Bronchoalveolar System | 10.3390/biom12081148 | 2022-08-20 |
| BCG and BCGΔBCG1419c transiently protect hypersusceptible I/St mice and induce different influx of macrophages and neutrophils during pulmonary tuberculosis | 10.1099/jmm.0.001485 | 2022-01-18 |
| Biofilms in tuberculosis: What have we learnt in the past decade and what is still unexplored? | 10.1016/j.tube.2021.102153 | 2022-01 |
| BCGΔBCG1419c increased memory CD8<sup>+</sup> T cell-associated immunogenicity and mitigated pulmonary inflammation compared with BCG in a model of chronic tuberculosis | 10.1038/s41598-022-20017-w | 2022 |
| Construction of Novel Live Genetically Modified BCG Vaccine Candidates Using Recombineering Tools | 10.1007/978-1-0716-1884-4_19 | 2022 |
| Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c | 10.1038/s41598-022-14935-y | 2022 |
| Understanding mycobacterial lipid metabolism and employing it as a tool to produce attenuated TB vaccine candidates | 10.1016/B978-0-323-91948-7.00013-0 | 2022 |
| After 100 Years of BCG Immunization against Tuberculosis, What Is New and Still Outstanding for This Vaccine? | 10.3390/vaccines10010057 | 2021-12 |
| New Insights into the Methylation of <i>Mycobacterium tuberculosis</i> Heparin Binding Hemagglutinin Adhesin Expressed in <i>Rhodococcus erythropolis</i> | 10.3390/pathogens10091139 | 2021-09 |
| Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG. | 10.1038/s41598-021-91993-8 | 2021-06-14 |
| Proteomic characterization of a second-generation version of the BCGΔBCG1419c vaccine candidate by means of electrospray-ionization quadrupole time-of-flight mass spectrometry | 10.1093/femspd/ftaa070 | 2021-01-16 |
| Preclinical evaluation of tuberculosis vaccine candidates: Is it time to harmonize study design and readouts for prioritizing their development? | 10.1016/j.vaccine.2020.11.073 | 2020-12-14 |
| Overexpression of the celA1 gene in BCG modifies surface pellicle, glucosamine content in biofilms, and affects in vivo replication | 10.1016/j.tube.2020.102005 | 2020-12 |
| Transcriptional portrait of M. bovis BCG during biofilm production shows genes differentially expressed during intercellular aggregation and substrate attachment | 10.1038/s41598-020-69152-2 | 2020-12 |
| Author Correction: BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines | 10.1038/s41541-020-00250-y | 2020-10-20 |
| Transcriptional and Mycolic Acid Profiling in Mycobacterium bovis BCG In Vitro Show an Effect for c-di-GMP and Overlap Between Dormancy and Biofilms | 10.4014/jmb.1911.11043 | 2020-06-28 |
| BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines | 10.1038/s41541-020-0169-6 | 2020-03-12 |
| Can immunization with Bacillus Calmette-Guérin be improved for prevention or therapy and elimination of chronic Mycobacterium tuberculosis infection? | 10.1080/14760584.2019.1704263 | 2019-12-02 |
| Macrophage infection with combinations of BCG mutants reduces induction of TNF-α, IL-6, IL-1β and increases IL-4 | 10.1016/j.tube.2019.01.005 | 2019-03 |
| Advanced hydrogels for treatment of diabetes | 10.1002/term.2880 | 2019 |
| BCG vaccination prevents reactivation of latent lymphatic murine tuberculosis independently of CD4<sup>+</sup> T cells | 10.3389/fimmu.2019.00532 | 2019 |
| Changes in Host Response to Mycobacterium tuberculosis Infection Associated With Type 2 Diabetes: Beyond Hyperglycemia | 10.3389/fcimb.2019.00342 | 2019 |
| New potential biomarkers to assess efficacy of protection afforded by vaccine candidates against tuberculosis | 10.1016/j.cmi.2019.02.010 | 2019 |
| BCG constitutively expressing the adenylyl cyclase encoded by Rv2212 increases its immunogenicity and reduces replication of M. tuberculosis in lungs of BALB/c mice | 10.1016/j.tube.2018.08.012 | 2018-12 |
| Vaccination of guinea pigs with BCGΔBCG1419c transiently reduces hematogenous spread of M. tuberculosis to the spleen | 10.1093/femspd/fty088 | 2018-11-30 |
| Modulation of autophagy as a strategy for development of new vaccine candidates against tuberculosis | 10.1016/j.molimm.2018.03.006 | 2018-05 |
| An opportunity to compare the effects of BCGMoreau and BCG-Russia in Brazil | 10.5588/ijtld.18.0271 | 2018 |
| Evaluation of the immunogenic capability of the BCG strains BCGΔBCG1419c and BCGΔBCG1416c in a three-dimensional human lung tissue model | 10.1016/j.vaccine.2018.02.044 | 2018 |
| Immune response elicited by two rBCG strains devoid of genes involved in c-di-GMP metabolism affect protection versus challenge with M. tuberculosis strains of different virulence | 10.1016/j.vaccine.2018.03.014 | 2018 |
| The BCGΔBCG1419c vaccine candidate reduces lung pathology, IL-6, TNF-α, and IL-10 during chronic TB infection | 10.3389/fmicb.2018.01281 | 2018 |
| Mice continue to be a good model for preliminary assessment of tuberculosis vaccine candidates | 10.1080/21645515.2016.1248010 | 2017 |
| Recent mouse models and vaccine candidates for preventing chronic/latent tuberculosis infection and its reactivation | 10.1093/femspd/ftx079 | 2017 |
| Uncovering the hidden: complexity and strategies for diagnosing latent tuberculosis | 10.15698/mic2017.11.596 | 2017 |
| A quantitative model for dermal infection and oedema in BALB/c mice pinna | 10.1186/s12866-016-0907-0 | 2016 |
| Multiantigenic subunitary vaccines against tuberculosis in clinical trials: Where do we stand and where do we need to go? | 10.1080/21645515.2015.1136760 | 2016 |
| The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo | 10.1016/j.vaccine.2016.08.035 | 2016 |
| Vaccines directed against microorganisms or their products present during biofilm lifestyle: Can we make a translation as a broad biological model to tuberculosis? | 10.3389/fmicb.2016.00014 | 2016 |
| Overexpression of DosR in Mycobacterium tuberculosis does not affect aerobic replication in vitro or in murine macrophages | 10.1007/s13213-014-0910-3 | 2015 |
| The adenylyl cyclase Rv2212 modifies the proteome and infectivity of Mycobacterium bovis BCG | 10.1007/s12223-014-0335-1 | 2015 |
| The cyclic di-GMP phosphodiesterase gene Rv1357c/BCG1419c affects BCG Pellicle production and in Vivo maintenance | 10.1002/iub.1353 | 2015 |
| Current approaches and models to develop and evaluate new vaccines and drugs against tuberculosis | No DOI available. | 2014 |
| Formation of mycobacterial pellicles in vitro and their possible impact on tuberculosis infection | 10.2174/1573398X10666140717185630 | 2014 |
| OmpR phosphorylation regulates ompS1 expression by differentially controlling the use of promoters | 10.1099/mic.0.071381-0 | 2014 |
| A DNA vaccine containing PPE68 induces humoral response in cattle | No DOI available. | 2013 |
| Expression of non-replicating persistence associated genes of Mycobacterium bovis in lymph nodes from skin test-reactor cattle | 10.1016/j.micpath.2013.04.012 | 2013 |
| Extensively drug-resistant tuberculosis (XDR-TB): Successful therapies used in the clinic to the disease,Tuberculosis extensamente resistente a antibióticos (TB-XDR): Terapias utilizadas con éxito en la clínica para curar la enfermedad | No DOI available. | 2013 |
| Mycobacterium bovis DNA detection in colostrum as a potential indicator of vaccination effectiveness against bovine tuberculosis | 10.1128/CVI.00566-12 | 2013 |
| The synthetic cathelicidin HHC-10 inhibits mycobacterium bovis BCG in vitro and in C57BL/6 mice | 10.1089/mdr.2012.0149 | 2013 |
| Transient expression and characterization of the antimicrobial peptide protegrin-1 in Nicotiana tabacum for control of bacterial and fungal mammalian pathogens | 10.1007/s11240-013-0344-9 | 2013 |
| Mycobacterium Tuberculosis Signaling via c-AMP | No DOI available. | 2012 |
| Vaccination of mice with recombinant bacille Calmette-Guérin harboring Rv1357c protects similarly to native BCG | 10.5588/ijtld.11.0735 | 2012 |
| Identification of immunodominant antigens of Mycobacterium bovis by expression library immunization | 10.1016/j.tvjl.2010.09.021 | 2011 |
| Mycobacterium tuberculosis TLR2 agonists LprA, LM and Man-LAM induce notch1 and socs3 transcription | No DOI available. | 2011 |
| Distribution of multidrug resistant bacteria in inanimate objects within stalls in Hidalgo, Mexico | 10.3923/javaa.2010.3008.3010 | 2010 |
| DosR-regulon genes induction in Mycobacterium bovis BCG under aerobic conditions | 10.1016/j.tube.2010.04.001 | 2010 |
| Global reemergence of tuberculosis: Are host defense peptides an option to ameliorate disease burden? | 10.1089/mdr.2009.0087 | 2010 |
| Modulation of cAMP metabolism in Mycobacterium tuberculosis and its effect on host infection | 10.1016/j.tube.2010.03.002 | 2010 |
| Molecular findings and approaches spotlighting Mycobacterium bovis persistence in cattle | 10.1051/vetres/2009005 | 2009 |
| Mycobacterium tuberculosis modulates its cell surface via an oligopeptide permease (Opp) transport system | 10.1096/fj.09-132407 | 2009 |
| LeuO antagonizes H-NS and StpA-dependent repression in Salmonella enterica ompS1 | 10.1111/j.1365-2958.2007.05958.x | 2007 |
| A positive regulatory loop controls expression of the locus of enterocyte effacement-encoded regulators Ler and GrlA | 10.1128/JB.187.23.7918-7930.2005 | 2005 |
| Negative Osmoregulation of the Salmonella ompS1 Porin Gene Independently of OmpR in an hns Background | 10.1128/JB.185.22.6497-6506.2003 | 2003 |